Endpoints News· @endpts · X·· 7 小时前精选AI 评分72
AI 导读
赛诺菲向再生元支付10亿美元首付款，获得四款长效免疫抗体，双方重启Dupixent背后的合作关系。此举发生在赛诺菲专利悬崖临近之际。
推荐理由
赛诺菲以10亿美元首付款引进四款长效免疫抗体，读者可借此观察其专利悬崖前的管线补位策略。
正文
Sanofi is paying Regeneron $1B upfront for four long-acting immunology antibodies, returning to the partnership behind Dupixent as its patent cliff nears.
https://endpoints.news/sanofi-builds-on-immunology-alliance-with-regeneron-for-1b-upfront/?utm_source=Twitter&utm_medium=organic_social&utm_campaign=editorial
来源：Endpoints News · x.com